Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Eiger BioPharmaceuticals Q2 EPS $(0.57) Misses $(0.55) Estimate, Sales $2.10M Miss $2.15M Estimate


Benzinga | Aug 5, 2021 05:01PM EDT

Eiger BioPharmaceuticals Q2 EPS $(0.57) Misses $(0.55) Estimate, Sales $2.10M Miss $2.15M Estimate

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 3.64 percent. This is a 5 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $2.10 million which missed the analyst consensus estimate of $2.15 million by 2.47 percent.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC